The role of cannabinoids in modulating emotional and nonemotional memory processes in the hippocampus

Frontiers in Behavioral Neuroscience

Volumn , Issue JUNE, 2011, Pages

  Akirav, Irit ^a  

^a UNIVERSITY OF HAIFA   (Israel)

Author keywords

Anxiety; Cannabinoids; CB1; Emotional memory; Extinction; Hippocampus; LTP; Receptors; Stress

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ACYLGLYCEROL LIPASE; ANANDAMIDE; CANNABIDIOL; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DIAZEPAM; DRONABINOL; FATTY ACID AMIDASE; LIPOPROTEIN LIPASE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; NABILONE; RIMONABANT; UNCLASSIFIED DRUG; URB 532;

ANXIETY; ANXIETY DISORDER; ARTICLE; AVERSION; CONDITIONING; DOSE RESPONSE; DRUG EFFICACY; EMOTIONALITY; FEAR; HIPPOCAMPUS; HUMAN; LEARNING DISORDER; LONG TERM DEPRESSION; LONG TERM POTENTIATION; LOW DRUG DOSE; MEMORY; MEMORY CONSOLIDATION; MEMORY DISORDER; NERVE CELL PLASTICITY; NONHUMAN; PANIC; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PROTEIN EXPRESSION; REINFORCEMENT; SPATIAL MEMORY; STRESS; TRANQUILIZING ACTIVITY; WORKING MEMORY;

EID: 84855222649     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2011.00034     Document Type: Article

References (157)

1. Abush, H., and Akirav, I. (2010). Cannabinoids modulate hippocampal memory and plasticity. Hippocampus 20, 1126-1138.
2. Arenos, J. D., Musty, R. E., and Bucci, D. J. (2006). Blockade of cannabinoid CB1 receptors alters contextual learning and memory. Eur. J. Pharmacol. 539, 177-183.
3. Bambico, F. R., Katz, N., Debonnel, G., and Gobbi, G. (2007). Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 27, 11700-11711.
4. Barad, M., Gean, P. W., and Lutz, B. (2006). The role of the amygdala in the extinction of conditioned fear. Biol. Psychiatry 60, 322-328.
5. Begg, M., Pacher, P., Bátkai, S., Osei-Hyiaman, D., Offertáler, L., Mo, F. M., Liu, J., and Kunos, G. (2005). Evidence for novel cannabinoid receptors. Pharmacol. Ther. 106, 133-145.
6. Behr, J., Wozny, C., Fidzinski, P., and Schmitz, D. (2009). Synaptic plasticity in the subiculum. Prog. Neurobiol. 89, 334-342.
7. Berrendero, F., and Maldonado, R. (2002). Involvement of the opioid system in the anxiolytic-like effects induced by G9-tetrahydrocannabinol. Psychopharmacology (Berl.) 163, 111-117.
8. Bielsky, I. F., and Young, L. J. (2004). Oxytocin, vasopressin, and social recognition in mammals. Peptides 25, 1565-1574.
9. Bisogno, T., Howell, F., Williams, G., Minassi, A., Cascio, M. G., Ligresti, A., Matias, I., Schiano-Moriello, A., Paul, P., Williams, E. J., Gangadharan, U., Hobbs, C., Di Marzo, V., and Doherty, P. (2003). Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol. 163, 463-468.
10. Bitencourt, R. M., Pamplona, F. A., and Takahashi, R. N. (2008). Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. Eur. Neuropsychopharmacol. 18, 849-859.
11. Bliss, T. V., and Gardner-Medwin, A. R. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the unanaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232, 357-374.
12. Bliss, T. V., and Lomo, T. (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232, 331-356.
13. Bohme, G. A., Laville, M., Ledent, C., Parmentier, M., and Imperato, A. (2000). Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 95, 5-7.
14. Bortolato, M., Campolongo, P., Mangieri, R. A., Scattoni, M. L., Frau, R., Trezza, V., La Rana, G., Russo, R., Calignano, A., Gessa, G. L., Cuomo, V., and Piomelli, D. (2006). Anxiolytic-like properties of the anandamide transport inhibitor AM404. Neuropsychopharmacology 31, 2652-2659.
15. Bouton, M. E., Westbrook, R. F., Corcoran, K. A., and Maren, S. (2006). Contextual and temporal modulation of extinction: behavioral and biological mechanisms. Biol. Psychiatry 60, 352-360.
16. Bremner, J. D., Randall, P., Scott, T. M., Bronen, R. A., Seibyl, J. P., Southwick, S. M., Delaney, R. C., McCarthy, G., Charney, D. S., and Innis, R. B. (1995). MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am. J. Psychiatry 152, 973-981.
17. Brodkin, J., and Moerschbaecher, J. M. (1997). SR141716A antagonizes the disruptive effects of can-nabinoid ligands on learning in rats. J. Pharmacol. Exp. Ther. 282, 1526-1532.
18. Charney, D. S., Deutch, A. Y., Krystal, J. H., Southwick, S. M., and Davis, M. (1993). Psychobiologic mechanisms of posttraumatic stress disorder. Arch. Gen. Psychiatry 50, 294-305.
19. Chevaleyre, V., Takahashi, K. A., and Castillo, P. E. (2006). Endocannabinoid-mediated synaptic plasticity in the CNS. Annu. Rev. Neurosci. 29, 37-76.
20. Chhatwal, J. P., Myers, K. M., Ressler, K. J., and Davis, M. (2005). Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J. Neurosci. 25, 502-506.
21. Chhatwal, J. P., and Ressler, K. J. (2007). Modulation of fear and anxiety by the endogenous cannabinoid system. CNS Spectr. 12, 211-220.
22. Collins, D. R., Pertwee, R. G., and Davies, S. N. (1994). The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur. J. Pharmacol. 11, R7-R8.
23. Collins, D. R., Pertwee, R. G., and Davies, S. N. (1995). Prevention by the can-nabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice. Br. J. Pharmacol. 115, 869-870.
24. Da, S., and Takahashi, R. N. (2002). SR 141716A prevents delta 9-tetrahydro-cannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 321-325.
25. Davies, S. N., Pertwee, R. G., and Riedel, G. (2002). Functions of cannabi-noid receptors in the hippocampus. Neuropharmacology 42, 993-1007.
26. De Kloet, E. R., Joëls, M., and Holsboer, F. (2005). Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463-475.
27. de Oliveira Alvares, L., de Oliveira, L. F., Camboim, C., Diehl, F., Genro, B. P., Lanziotti, V. B., and Quillfeldt, J. A. (2005). Amnestic effect of intrahip-pocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats. Neurobiol. Learn. Mem. 83, 119-124.
28. de Oliveira Alvares, L., Genro, B. P., Vaz Breda, R., Pedroso, M. F., Da Costa, J. C., and Quillfeldt, J. A. (2006). AM251, a selective antagonist of the CB1 receptor, inhibits the induction of long-term potentiation and induces retrograde amnesia in rats. Brain Res. 1075, 60-67.
29. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
30. Di Marzo, V. (2008). Endocannabinoids: synthesis and degradation. Rev. Physiol. Biochem. Pharmacol. 160, 1-24.
31. Egashira, N., Mishima, K., Iwasaki, K., and Fujiwara, M. (2002). Intracerebral microinjections of delta 9-tetrahydro-cannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Res. 952, 239-245.
32. Fanselow, M. S. (1998). Pavlovian conditioning, negative feedback, and blocking: mechanisms that regulate association formation. Neuron 20, 625-627.
33. Ferguson, J. N., Aldag, J. M., Insel, T. R., and Young, L. J. (2001). Oxytocin in the medial amygdala is essential for social recognition in the mouse. J. Neurosci. 21, 278-8285.
34. Ferrari, F., Ottani, A., Vivoli, R., and Giuliani, D. (1999). Learning impairment produced in rats by the cannabi-noid agonist HU 210 in a water-maze task. Pharmacol. Biochem. Behav. 64, 555-561.
35. Finn, D., Beckett, S., Richardson, D., Kendall, D., Marsden, C., and Chapman, V. (2004). Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors. Eur. J. Neurosci. 20, 848-852.
36. Freund, T. F., Katona, I., and Piomelli, D. (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017-1066.
37. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., and Casellas, P. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54-61.
38. Ganon-Elazar, E., and Akirav, I. (2009). Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J. Neurosci. 29, 11078-11088.
39. Gaoni, Y., and Mechoulam, R. (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc. 86, 1646-1647.
40. Gorzalka, B. B., Hill, M. N., and Hillard, C. J. (2008). Regulation of endocan-nabinoid signaling by stress: implications for stress-related affective disorders. Neurosci. Biobehav. Rev. 32, 1152-1160.
41. Hajos, N., Katona, I., Naiem, S., MacKie, K., Ledent, C., Mody, I., and Freund, T. (2000). Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 12, 3239-1349.
42. Hall, W., and Solowij, N. (1998). Adverse effects of cannabis. Lancet 352, 1611-1616.
43. Haller, J., Bakos, N., Szirmay, M., Ledent, C., and Freund, T. (2002). The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur. J. Neurosci. 16, 1395-1398.
44. Haller, J., Varga, B., Ledent, C., Barna, I., and Freund, T. (2004). Context-dependent effects of CB1 cannabi-noid gene disruption on anxiety-like and social behaviour in mice. Eur. J. Neurosci. 19, 1906-1912.
45. Hampson, R. E., and Deadwyler, S. A. (1999). Cannabinoids, hippocampal function and memory. Life Sci. 65, 715-723.
46. Hampson, R. E., and Deadwyler, S. A. (2000). Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J. Neurosci. 20, 8932-8942.
47. Häring, M., Marsicano, G., Lutz, B., and Monory, K. (2007). Identification of the cannabinoid receptor type 1 in serotonergic cells of raphe nuclei in mice. Neuroscience 146, 1212-1219.
48. Harkany, T., Dobszay, M., Cayetanot, F., Härtig, W., Siegemund, T., Aujard, F., and Mackie, K. (2005). Redistribution of CB1 cannabinoid receptors during evolution of cholinergic basal forebrain territories and their cortical projection areas: A comparison between the gray mouse lemur (microcebus murinus, primates) and rat. Neuroscience 135, 595-609.
49. Herkenham, M., Lynn, A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R., and Rice, K. C. (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563-583.
50. Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., and Rice, K. C. (1990). Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U.S.A. 87, 1932-1936.
51. Heyser, C. J., Hampson, R. E., and Deadwyler, S. A. (1993). Effects of tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J. Pharmacol. Exp. Ther. 264, 294-307.
52. Hill, M. N., and Gorzalka, B. B. (2009). The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol. Disord. Drug Targets 8, 451-458.
53. Hill, M. N., Karacabeyli, E. S., and Gorzalka, B. B. (2007). Estrogen recruits the endocannabinoid system to modulate emotionality. Psychoneuroendocrinology 32, 350-357.
54. Hill, M. N., Patel, S., Campolongo, P., Tasker, J. G., Wotjak, C. T., and Bains, J. S. (2010). Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J. Neurosci. 10, 14980-14986.
55. Hoffman, A. F., and Lupica, C. R. (2000). Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J. Neurosci. 20, 2470-2479.
56. Hoffman, A. F., Oz, M., Caulder, T., and Lupica, C. R. (2003). Functional tolerance and blockade of long-term depression at synapses in the nucleus accumbens after chronic cannabinoid exposure. J. Neurosci. 23, 4815-4820.
57. Hoffman, A. F., Oz, M., Yang, R., Lichtman, A. H., and Lupica, C. R. (2007). Opposing actions of chronic {Delta} 9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn. Mem. 14, 63-74.
58. Hölter, S. M., Kallnik, M., Wurst, W., Marsicano, G., Lutz, B., and Wotjak, C. T. (2005). Cannabinoid CB1 receptor is dispensable for memory extinction in an appetitively-motivated learning task. Eur. J. Pharmacol. 510, 69-74.
59. Joëls, M., and Baram, T. Z. (2009). The neuro-symphony of stress. Nat. Rev. Neurosci. 10, 459-466.
60. Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M., Palmery, M., Cuomo, V., and Piomelli, D. (2003). Modulation of anxiety through block-ade of anandamide hydrolysis. Nat. Med. 9, 76-81.
61. Katona, I., Rancz, E. A., Acsády, L., Ledent, C., Mackie, K., Hajos, N., and Freund, T. F. (2001). Distribution of CB1 cannabinoid receptors in the amyg-dala and their role in the control of GABAergic transmission. J. Neurosci. 21, 9506-9518.
62. Katona, I., Sperlagh, B., Sik, A., Kafalvi, A., Vizi, E. S., Mackie, K., and Freund, T. F. (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci.19, 4544-4558.
63. Katona, I., Urban, G. M., Wallace, M., Ledent, C., Jung, K. M., Piomelli, D., Mackie, K., and Freund, T. F. (2006). Molecular composition of the endo-cannabinoid system at glutamatergic synapses. J. Neurosci. 26, 5628-5637.
64. Kawamura, Y., Fukaya, M., Maejima, T., Yoshida, T., Miura, E., Watanabe, M., Ohno-Shosaku, T., and Kano, M. (2006). The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 26, 2991-3001.
65. Kogan, J. H., Frankland, P. W., and Silva, A. J. (2000). Long-term memory under-lying hippocampus-dependent social recognition in mice. Hippocampus 10, 47-56.
66. Kogan, N., and Mechoulam, R. (2006). The chemistry of endocannabinoids. J. Endocrinol. Invest. 29, 3-14.
67. Lafenêtre, P., Chaouloff, F., and Marsicano, G. (2007). The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Pharmacol. Res. 56, 367-381.
68. LeDoux, J. (2003). The emotional brain, fear, and the amygdala. Cell. Mol. Neurobiol. 23, 727-738.
69. Lichtman, A. H., Dimen, K. R., and Martin, B. R. (1995). Systemic or intra-hippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119, 282-290.
70. Lichtman, A. H., and Martin, B. R. (1996). Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology (Berl.) 126, 125-131.
71. Lin, H. C., Mao, S. C., Chen, P. S., and Gean, P. (2008). Chronic cannabinoid administration in vivo compromises extinction of fear memory. Learn. Mem. 15, 876-884.
72. Lin, H. C., Mao, S. C., Su, C. L., and Gean, P. W. (2009). The role of prefrontal cortex CB1 receptors in the modulation of fear memory. Cereb. Cortex 19, 165-175.
73. Linszen, D., and van Amelsvoort, T. (2007). Cannabis and psychosis: an update on course and biological plausible mechanisms. Curr. Opin. Psychiatry 20, 116-120.
74. Lutz, B. (2007). The endocannabinoid system and extinction learning. Mol. Neurobiol. 36, 92-101.
75. Lutz, B. (2009). Endocannabinoid signals in the control of emotion. Curr. Opin. Pharmacol. 9, 46-52.
76. Maccarrone, M., Valverde, O., Barbaccia, M. L., Castañé, A., Maldonado, R., Ledent, C., Parmentier, M., and Finazzi-Agrò, A. (2002). Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur. J. Neurosci. 15, 1178-1186.
77. Mackie, K. (2005). Distribution of can-nabinoid receptors in the central and peripheral nervous system. Handb. Exp Pharmacol. 168, 299-325.
78. Mallet, P. E., and Beninger, R. J. (1998). The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta-9-tetrahydrocannabinol or anandamide. Psychopharmacology 140, 11-19.
79. Maren, S., and Quirk, G. J. (2004). Neuronal signalling of fear memory. Nat. Rev. Neurosci. 5, 844-852.
80. Marsch, R., Foeller, E., Rammes, G., Bunck, M., Kossl, M., Holsboer, F., Zieglgänsberger, W., Landgraf, R., Lutz, B., and Wotjak, C. T. (2007). Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanil-loid type 1 receptor-deficient mice. J. Neurosci. 27, 832-839.
81. Marsicano, G., and Lutz, B. (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11, 4213-4225.
82. Marsicano, G., and Lutz, B. (2006). Neuromodulatory functions of the endocannabinoid system. J. Endocrinol. Invest. 29, 27-46.
83. Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, G., Zieglansberger, W., Di Marzo, V., and Lutz, B. (2002).The endogenous cannabinoid system controls extinction of aversive memories. Nature 418, 530-534.
84. Martin, M., Ledent, C., Parmentier, M., Maldonado, R., and Valverde, O. (2002). Involvement of CB1 cannabi-noid receptors in emotional behaviour. Psychopharmacology (Berl.) 159, 379-387.
85. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
86. McEwen, B. C., and Gould, E. (1990). Adrenal steroid influences on the survival of hippocampal neurons. Biochem. Pharmacol. 40, 2393-2402.
87. McEwen, B. S. (1999). Stress and hip-pocampal plasticity. Annu. Rev. Neurosci. 22, 105-122.
88. Meaney, M. J. (2001). Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations. Neuroscience 24, 1161-1192.
89. Mikics, É., Dombi, T., Barsvári, B., Varga, B., Ledent, C., Freund, T. F., and Haller, J. (2006). The effects of cannabinoids on contextual conditioned fear in CB1 knockout and CD1 mice. Behav. Pharmacol. 17, 223-230.
90. Milad, M. R., Orr, S. P., Lasko, N. B., Chang, Y., Rauch, S. L., and Pitman, R. K. (2008). Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J. Psychiatr. Res. 42, 515-520.
91. Milad, M. R., and Quirk, G. J. (2002). Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 420, 70-74.
92. Milad, M. R., Rauch, S. L., Pitman, R. K., and Quirk, G. J. (2006). Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol. Psychol. 73, 61-71.
93. Mishima, K., Egashira, N., Hirosawa, N., Fujii, M., Matsumoto, Y., Iwasaki, K., and Fujiwara, M. (2001). Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats. Jpn. J. Pharmacol. 87, 297-308.
94. Misner, D. L., and Sullivan, J. M. (1999). Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci. 19, 6795-6805.
95. Moise, A. M., Eisenstein, S. A., Astarita, G., Piomelli, D., and Hohmann, A. G. (2008). An endocannabinoid signaling system modulates anxiety-like behavior in male syrian hamsters. Psychopharmacology (Berl.) 200, 333-346.
96. Monory, K., Massa, F., Egertová, M., Eder, M., Blaudzun, H., Westenbroek, R., Kelsch, W., Jacob, W., Marsch, R., Ekker, M., Long, J., Rubenstein, J. L., Goebbels, S., Nave, K. A., During, M., Klugmann, M., Wölfel, B., Dodt, H. U., Zieglgänsberger, W., Wotjak, C. T., Mackie, K., Elphick, M. R., Marsicano, G., and Lutz, B. (2006). The endocan-nabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51, 455-466.
97. Moreira, F. A., Aguiar, D. C., and Guimarães, F. S. (2007). Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaque-ductal gray. Neuropharmacology 52, 958-965.
98. Moreira, F. A., Kaiser, N., Monory, K., and Lutz, B. (2008). Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 54, 141-150.
99. Moreira, F. A., and Lutz, B. (2008). The endocannabinoid system: emotion, learning and addiction. Addict. Biol. 13, 196-212.
100. Nakamura, E. M., da Silva, E. A., Concilio, G. V., Wilkinson, D. A., and Masur, J. (1991). Reversible effects of acute and long-term administration of Δ9-tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend. 28, 167-175.
101. Niyuhire, F., Varvel, S. A., Thorpe, A. J., Stokes, R. J., Wiley, J. L., and Lichtman, A. H. (2007). The disruptive effects of the CB 1 receptor antagonist rimonabant on extinction learning in mice are task-specific. Psychopharmacology (Berl.) 191, 223-231.
102. Nowicky, A. V., Teyler, T. J., and Vardaris, R. M. (1987). The modulation of long term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro. Brain Res. Bull. 19, 663-672.
103. Nyíri, G., Cserép, C., Szabadits, E., Mackie, K., and Freund, T. F. (2005). CB1 can-nabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 136, 811-822.
104. Ohno-Shosaku, T., Maejima, T., and Kano, M. (2001). Endogenous can-nabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29, 729-738.
105. Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., and Ueda, N. (2004). Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem. 279, 5298-5305.
106. Onaivi, E., Green, M., and Martin, B. (1990). Pharmacological characterization of cannabinoids in the elevated plus maze. J. Pharmacol. Exp. Ther. 253, 1002-1009.
107. Onaivi, E. S., Ishiguro, H., Gong, J.-P., Patel, S., Perchuk, A., Meozzi, P. A, Myers, L., Mora, Z., Tagliaferro, P., Gardner, E., Brusco, A., Akinshola, B. E., Liu, Q. R., Hope, B., Iwasaki, S., Arinami, T., Teasenfitz, L., and Uhl, G.R. (2006). Discovery of the presence and functional expression of cannabi-noid CB2 receptors in brain. Ann. N.Y. Acad. Sci. 1074, 514-536.
108. Oropeza, V. C., Mackie, K., and Van Bockstaele, E. J. (2007). Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res. 1127, 36-44.
109. O'Shea, M., Singh, M. E., McGregor, I. S., and Mallet, P. E. (2004). Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J. Psychopharmacol. 18, 502-508.
110. Pamplona, F. A., Bitencourt, R. M., and Takahashi, R. N. (2008). Short-and long-term effects of cannabinoids on the extinction of contextual fear memory in rats. Neurobiol. Learn. Mem. 90, 290-293.
111. Pamplona, F. A., Prediger, R. D. S., Pandolfo, P., and Takahashi, R. N. (2006). The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats. Psychopharmacology (Berl.) 188, 641-649.
112. Patel, S., and Hillard, C. J. (2006). Pharmacological evaluation of can-nabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J. Pharmacol. Exp. Ther. 318, 304-311.
113. Phelps, E. A., Delgado, M. R., Nearing, K. I., and LeDoux, J. E. (2004). Extinction learning in humans: role of the amygdala and vmPFC. Neuron 43, 897-905.
114. Pitman, R. K., Gilbertson, M. W., Gurvits, T. V., May, F. S., Lasko, N. B., Metzger, L. J., Shenton, M. E., Yehuda, R., Orr, S. P., and Harvard/VA PTSD Twin Study Investigators. (2006). Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure. Ann. N. Y. Acad. Sci. 1071, 242-254.
115. Quirk, G. J., Garcia, R., and González-Lima, F. (2006). Prefrontal mechanisms in extinction of conditioned fear. Biol. Psychiatry 60, 337-343.
116. Rauch, S. L., Shin, L. M., and Phelps, E. A. (2006). Neurocircuitry models of posttraumatic stress disorder and extinction: human neuroimaging research -past, present, and future. Biol. Psychiatry 60, 376-382.
117. Reich, C. G., Mohammadi, M. H., and Alger, B. E. (2008). Endocannabinoid modulation of fear responses: learning and state-dependent performance effects. J. Psychopharmacol. 22, 769-777.
118. Resstel, L. B. M., Lisboa, S., Aguiar, D., Corrêa, F. M. A., and Guimaraes, F. (2008). Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats. Psychopharmacology (Berl.) 198, 405-411.
119. Ribeiro, A., Ferraz-de-Paula, V., Pinheiro, M., and Palermo-Neto, J. (2009). Dose-response effects of systemic anandamide administration in mice sequentially submitted to the open field and elevated plus-maze tests. Braz. J. Med. Biol. Res. 42, 556-560.
120. Riedel, G., and Davies, S. N. (2005). Cannabinoid function in learning, memory and plasticity. Handb. Exp. Pharmacol. 168, 445-477.
121. Robinson, L., Hinder, L., Pertwee, R. G., and Riedel, G. (2003). Effects of delta-9-THC and WIN 55,212-2 on place preference in the water maze in rats. Psychopharmacology (Berl.) 166, 40-50.
122. Rodriguez de Fonseca, F., Rubio, P., Menzaghi, F., Merlo-Pich, E., Rivier, J., Koob, G. F., and Navarro, M. (1996). Corticotropin-releasing factor (CRF) antagonist [D-Phe12, Nle21, 38, C alpha MeLeu37] CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J. Pharmacol. Exp. Ther. 276, 56-64.
123. Roohbakhsh, A., Moghaddam, A. H., Massoudi, R., and Zarrindast, M. R. (2007). Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. Clin. Exp. Pharmacol. Physiol. 34, 223-229.
124. Ross, R. A. (2003). Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140, 790-801.
125. Rothbaum, B. O., and Davis, M. (2003). Applying learning principles to the treatment of post-trauma reactions. Ann. N. Y. Acad. Sci. 1008, 112-121.
126. Rubino, T., Guidali, C., Vigano, D., Realini, N., Valenti, M., Massi, P., and Parolaro, D. (2008a). CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology 54, 151-160.
127. Rubino, T., Realini, N., Castiglioni, C., Guidali, C., Viganó, D., Marras, E., Petrosino, S., Perletti, G., Maccarrone, M., Di Marzo, V., and Parolaro, D. (2008b). Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb. Cortex 18, 1292-1301.
128. Sapolsky, R. M. (1996). Why stress is bad for your brain. Science 273, 749-750.
129. Schat, A. R., Lee, M., Condie, R. B., Pulaski, J. T., and Kaminski, N. E. (1997). Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142, 278-287.
130. Scherma, M., Medalie, J., Fratta, W., Vadivel, S. K., Makriyannis, A., Piomelli, D., Mikics, E., Haller, J., Yasar, S., Tanda, G., and Goldberg, S. R. (2008). The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Neuropharmacology 54, 129-140.
131. Segev, A., and Akirav, I. (2011). Differential effects of cannabinoid receptor agonist on social discrimination and contextual fear in amygdala and hippocampus. Learn. Mem. 18, 254-259.
132. Sheline, Y. I., Sanghavi, M., Mintun, M. A., and Gado, M. H. (1999). Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neurosci. 19, 5034-5043.
133. Shen, M., Piser, T. M., Seybold, V. S., and Thayer, S. A. (1996). Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16, 4322-4334.
134. Shin, L. M., and Liberzon, I. (2010). The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35, 169-191.
135. Slanina, K. A., Roberto, M., and Schweitzer, P. (2005). Endocannabinoids restrict hippocampal long term potentiation via CB1. Neuropharmacology 49, 660-668.
136. Sokal, D. M., Benetti, C., Girlanda, E., and Large, C. H. (2008). The CB1 receptor antagonist, SR141716A, prevents high-frequency stimulation-induced reduction of feedback inhibition in the rat dentate gyrus following perforant path stimulation in vivo. Brain Res. 1223, 50-58.
137. Steiner, M. A., Marsicano, G., Nestler, E. J., Holsboer, F., Lutz, B., and Wotjak, C. T. (2008). Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 33, 54-67.
138. Suenaga, T., and Ichitani, Y. (2008). Effects of hippocampal administration of a cannabinoid receptor agonist WIN 55,212-2 on spontaneous object and place recognition in rats. Behav. Brain Res. 190, 248-252.
139. Suenaga, T., Kaku, M., and Ichitani, Y. (2008). Effects of intrahippocampal cannabinoid receptor agonist and antagonist on radial maze and T-maze delayed alternation performance in rats. Pharmacol. Biochem. Behav. 91, 91-96.
140. Sullivan, J. M. (2000). Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids. Learn. Mem. 7, 132-139.
141. Suzuki, A., Josselyn, S. A., Frankland, P., Masushige, S., Silva, A. J., and Kida, S. (2004). Memory reconsolidation and extinction have distinct temporal and biochemical signatures. J. Neurosci. 24, 4787-4795.
142. Taber, K. H., and Hurley, R. A. (2009). Endocannabinoids: stress, anxiety, and fear. J. Neuropsychiatry Clin. Neurosci. 21, 108-113.
143. Terranova, J. P., Michaud, J. C., Le Fur, G., and Soubrie, P. (1995). Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedebergs Arch. Pharmacol. 352, 576-579.
144. Tsou, K., Brown, S., Sanudo-Pena, M. C., Mackie, K., and Walker, J. M. (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83, 393-411.
145. Urigüen, L., Pérez-Rial, S., Ledent, C., Palomo, T., and Manzanares, J. (2004). Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46, 966-973.
146. Van den Berg, C. L., Hol, T., Van Ree, J. M., Spruijt, B. M., Everts, H., and Koolhaas, J. M. (1999). Play is indispensable for an adequate development of coping with social challenges in the rat. Dev. Psychobiol. 34, 129-138.
147. Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., Marnett, L. J., Di Marzo, V., Pittman, Q. J., Patel, K. D., and Sharkey, K. A. (2005). Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310, 329-332.
148. Van Wimersma Greidanus, T. B., and Maigret, C. (1996). The role of limbic vasopressin and oxytocin in social recognition. Brain Res. 713, 153-159.
149. Varvel, S. A., Anum, E. A., and Lichtman, A. H. (2005). Disruption of CB1 receptor signaling impairs extinction of spatial memory in mice. Psychopharmacology (Berl.) 179, 863-872.
150. Varvel, S. A., Hamm, R. J., Martin, B. R., and Lichtman, A. H. (2001). Differential effects of delta9-THC on spatial reference and working memory in mice. Psychopharmacology (Berl.) 157, 142-150.
151. Varvel, S. A., Wise, L. E., Niyuhire, F., Cravatt, B. F., and Lichtman, A. H. (2007). Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. Neuropsychopharmacology 32, 1032-1041.
152. Viveros, M., Marco, E., Llorente, R., and Lopez-Gallardo, M. (2007). Endocannabinoid system and synaptic plasticity: implications for emotional responses. Neural Plast. 2007, 52908.
153. Viveros, M., Marco, E. M., and File, S. E. (2005). Endocannabinoid system and stress and anxiety responses. Pharmacol. Biochem. Behav. 81, 331-342.
154. Wegener, N., Kuhnert, S., Thuns, A., Roese, R., and Koch, M. (2008). Effects of acute systemic and intra-cerebral stimulation of cannabinoid receptors on sensorimotor gating, locomotion and spatial memory in rats. Psychopharmacology (Berl.) 198, 375-385.
155. Wessa, M., and Flor, H. (2007). Failure of extinction of fear responses in post-traumatic stress disorder: evidence from second-order conditioning. Am. J. Psychiatry 164, 1684-1692.
156. Woon, F. L., and Hedges, D. W. (2008). Hippocampal and amygdala volumes in children and adults with childhood maltreatment-related posttraumatic stress disorder: a meta-analysis. Hippocampus 18, 729-736.
157. Yim, T. T., Hong, N. S., Ejaredar, M., McKenna, J. E., and McDonald, R. J. (2008). Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus. Neuroscience 151, 929-936.